The effect of vitamin C and E in the treatment and clinical course of patients with SARS-cov2 (COVID-19)
Phase 2
- Conditions
- SARS-cov2(COVID-19).COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20180425039414N3
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
18 years of age or older
Diagnosis of COVID-19 by RT PCR and CT scan of the lungs
Blood oxygen levels are between 90 and 93 percent
Breathing rate between 20 and 24 per minute
Heart rate between 100 and 130 beats per minute
Exclusion Criteria
Intubation (mechanical ventilation)
Shortness of breath caused by cardiogenic pulmonary edema
Pregnancy and lactation
Patients with end stage, lung, malignant, G6PD deficiency, diabetic ketoacidosis, cardiac arrhythmia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical response. Timepoint: During hospitalizatio. Method of measurement: Cessation of fever, improvement of shortness of breath, reduction of cough, blood oxygenation (SaO2) and hemodynamic parameters.;Mortality. Timepoint: During hospitalizatio. Method of measurement: Count the number of dead patients.;Hospital stay. Timepoint: During hospitalizatio. Method of measurement: Count the number of hospital days to improve clinical symptoms.
- Secondary Outcome Measures
Name Time Method